BioIntervene
San Diego, US · Founded 2014 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
DS
Daniela SalveminiNamed on SEC filing
GJ
Gary J. BennettNamed on SEC filing
Board
EH
GP
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.8M disclosed across 2 rounds · 2019–2021
▶$5.6MraisedJun 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$5.6MraisedJun 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ed HurwitzDirector
- Simon TateDirector
- Gary J. BennettDirector
- David BredtDirector
- Daniela SalveminiDirector
- Gary PatouDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedMar 2019 · 5 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedMar 2019 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniela SalveminiDirector
- Gary J. BennettExecutive Officer, Director
- Ed HurwitzDirector
- Gary PatouDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are BioIntervene's investors?
- BioIntervene's investors include MPM BioImpact.
- How much funding has BioIntervene raised?
- BioIntervene has disclosed $8.8M raised across 2 rounds.
- Where is BioIntervene headquartered?
- BioIntervene is headquartered in San Diego, US.